PRESS RELEASE published on 10/11/2024 at 07:30, 1 year 9 months ago Rapports financiers et d'audit annuels / Modalités de mise à disposition du rapport financier annuel Poxel annonce la mise à disposition de son Document d'Enregistrement Universel 2023 auprès de l'AMF pour l'exercice clos au 31 décembre 2023, incluant rapports financiers et sociaux AMF Maladies Métaboliques Document D'Enregistrement Universel Traitements Innovants Poxel
BRIEF published on 10/03/2024 at 18:35, 1 year 9 months ago Poxel annonce ses résultats financiers et stratégiques pour 2023 Résultats Financiers Biopharmaceutique TWYMEEG® Poxel OrbiMed
BRIEF published on 10/03/2024 at 18:35, 1 year 9 months ago Poxel announces its financial and strategic results for 2023 Financial Results Biopharmaceutical TWYMEEG® Poxel OrbiMed
PRESS RELEASE published on 10/03/2024 at 18:30, 1 year 9 months ago Informations privilégiées / Communiqué sur comptes, résultats Poxel publie ses résultats financiers pour l'année 2023 et dresse un bilan de ses activités. Accord avec OrbiMed, webinaires de présentation et perspectives de croissance Résultats Financiers Croissance Webinaires Poxel OrbiMed
BRIEF published on 09/30/2024 at 07:35, 1 year 9 months ago Poxel Secures $50M Non-Dilutive Financing from OrbiMed Non-dilutive Financing TWYMEEG® Poxel Royalty Monetization OrbiMed
BRIEF published on 09/30/2024 at 07:35, 1 year 9 months ago Poxel obtient un financement non dilutif de 50 millions de dollars auprès d'OrbiMed Financement Non Dilutif TWYMEEG® Poxel Monétisation Des Redevances OrbiMed
PRESS RELEASE published on 09/30/2024 at 07:30, 1 year 9 months ago Inside Information / Other news releases Poxel monetizes TWYMEEG® royalties in a USD 50 million deal with OrbiMed. Proceeds to reduce debt and support rare disease activities. Webinars scheduled for investor updates Webinars Royalties TWYMEEG® Poxel OrbiMed
BRIEF published on 09/09/2024 at 07:35, 1 year 10 months ago POXEL annonce une hausse significative de ses ventes au deuxième trimestre 2024 Partenariats Trésorerie Ventes TWYMEEG® Poxel
BRIEF published on 09/09/2024 at 07:35, 1 year 10 months ago POXEL announces a significant increase in its sales in the second quarter of 2024 Sales Treasury Partnerships TWYMEEG® Poxel
PRESS RELEASE published on 09/09/2024 at 07:30, 1 year 10 months ago Informations privilégiées / Autres communiqués Poxel annonce ses chiffres pour le T2 et S1 2024, avec hausse des ventes de TWYMEEG® au Japon et bilan des activités. Discussions en cours pour monétisation des redevances et horizon financier solide Chiffre D'affaires Japon Poxel TWYMEEG Redevances
Published on 07/16/2026 at 00:40, 5 hours 48 minutes ago Revive Therapeutics Announces Closing of First Tranche of Non-Brokered Private Placement
Published on 07/15/2026 at 23:00, 7 hours 28 minutes ago Battery X Metals Completes First-Generation Proprietary Battery Adaptor for Tesla Model 3 and Model Y, Marking a Significant Commercial Readiness Milestone for its Patent-Pending Lithium-Ion Battery Rebalancing Platform
Published on 07/15/2026 at 22:45, 7 hours 43 minutes ago Mako Mining Announces Q2 2026 Production Results with Record Gold Sold of 14,610 Au oz., Revenues of ~US$63 Million and Cash and Securities Balance of US$112 Million
Published on 07/15/2026 at 22:15, 8 hours 13 minutes ago Loar Holdings Inc. Announces Date and Time for Second Quarter 2026 Earnings and Conference Call
Published on 07/15/2026 at 14:30, 15 hours 58 minutes ago Avant Brands Reports Q2 2026 Results Highlighted by 34% Growth in Recreational Revenue
Published on 07/16/2026 at 04:55, 1 hour 32 minutes ago Finding Calm in the Roar: Hisense Creates More Inclusive FIFA World Cup 2026™ Experiences for Fans Across All 16 Host Cities
Published on 07/16/2026 at 01:01, 5 hours 26 minutes ago EQS-Adhoc: Circus Adjusts FY2026 Financial Guidance; Sharpens Focus on Operational Scalability
Published on 07/15/2026 at 20:14, 10 hours 14 minutes ago EQS-Adhoc: Bajaj Mobility AG: Preliminary figures for Q2 / 2026
Published on 07/15/2026 at 19:42, 10 hours 46 minutes ago EQS-Adhoc: Cherry SE: Adjusted EBITDA for the first half of 2026 significantly above prior-year operating result
Published on 07/15/2026 at 17:45, 12 hours 43 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of June 30, 2026
Published on 07/15/2026 at 17:45, 12 hours 43 minutes ago Half yearly report on the liquidity contract
Published on 07/15/2026 at 17:45, 12 hours 43 minutes ago Nombre total de droits de vote et actions composant le capital social au 30 juin 2026
Published on 07/15/2026 at 17:40, 12 hours 48 minutes ago Déclaration des transactions sur actions propres réalisées du 8 au 14 juillet 2026
